UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010370 |
|---|---|
| Receipt number | R000012135 |
| Scientific Title | Phase II study on reduction of mucous membrane inflammation by the nutritional supplement Elental in concurrent chemoradiotherapy for head and neck squamous cell carcinoma |
| Date of disclosure of the study information | 2013/04/01 |
| Last modified on | 2018/04/24 10:13:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/03/31 03:36:03 | ||
| 2 | Update | 2013/09/30 16:47:22 | Email |
|
| 3 | Update | 2013/09/30 16:47:52 | Recruitment status |
|
| 4 | Update | 2013/11/05 12:50:46 | Key inclusion criteria Key inclusion criteria |
|
| 5 | Update | 2013/11/05 12:51:33 | Recruitment status Anticipated trial start date |
|
| 6 | Update | 2014/03/31 18:56:12 | Anticipated trial start date |
|
| 7 | Update | 2014/12/03 19:39:45 | Key inclusion criteria Key inclusion criteria |
|
| 8 | Update | 2014/12/03 19:40:50 | Anticipated trial start date Last follow-up date |
|
| 9 | Update | 2015/02/28 15:59:03 | Anticipated trial start date |
|
| 10 | Update | 2015/09/30 21:16:39 | Recruitment status |
|
| 11 | Update | 2016/10/03 08:05:05 | Last follow-up date |
|
| 12 | Update | 2017/08/15 10:06:45 | Name of primary person or sponsor Organization |
|
| 13 | Update | 2017/08/15 19:19:50 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 14 | Update | 2018/04/24 10:13:31 | Publication of results |
